| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/23/2000 | CN1264302A Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 08/23/2000 | CN1264301A Prophylactic or therapeutic agent for amnesia |
| 08/23/2000 | CN1264300A Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
| 08/23/2000 | CN1264299A Improved rapidly disintegratable multiparticulate tablet |
| 08/23/2000 | CN1264296A Powder compositions of unilamellar liposomes |
| 08/23/2000 | CN1264295A Lipid complexes and liposomes of highly insoluble platinum complexes |
| 08/23/2000 | CN1263889A Monoclinic system sheet crystal tazhanot |
| 08/23/2000 | CN1263774A Organic trace elements supplement |
| 08/23/2000 | CN1263764A Medicine for treating eczema and its preparing process |
| 08/23/2000 | CN1263763A Drug composition containing carboxyl oxime acide derivative |
| 08/23/2000 | CN1263762A Cosmetic composite and method for reducing skin aging procedure |
| 08/23/2000 | CN1055697C Phospholipi derivatives containing higher elements of the Vth main group |
| 08/23/2000 | CN1055694C Novel process for isolation of clavulanic acid and of pharmaceutically acceptable salts |
| 08/23/2000 | CN1055693C Bioavailable crystalline form of cefuronime axetil |
| 08/23/2000 | CN1055691C 3-alkylcarbonyl-thiadiazinenone |
| 08/23/2000 | CN1055690C 4-aryloxy-and-4-arylthiopiperidine derivatives, method for preparation them, medicine compound containing them and use thereof |
| 08/23/2000 | CN1055687C Novel piperazine carboxamides |
| 08/23/2000 | CN1055684C Method for preparing substituted pyridine |
| 08/23/2000 | CN1055636C External ointment for eczema and dermatitis |
| 08/23/2000 | CN1055629C Making up method for medicinal liquid of ice guide therapeutic method on channels and acupuncture point |
| 08/23/2000 | CN1055622C Use of root of Chinese pulsatilla for preparing preparation for treating lung cancor and gastric cancer |
| 08/23/2000 | CN1055619C Health-care cigarette plaster and preparation method thereof |
| 08/23/2000 | CA2299119A1 A method of stabilizing and/or isolating nucleic acids |
| 08/22/2000 | USRE36832 N-heteroaryl-N'-phenylurea derivatives, their production and use |
| 08/22/2000 | USRE36831 Iron-pyridone complexes for anemia |
| 08/22/2000 | US6107520 Spisulosine compounds |
| 08/22/2000 | US6107517 Thyroid hormone agonists and antagonists |
| 08/22/2000 | US6107499 Dopamine analog amide |
| 08/22/2000 | US6107494 Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 08/22/2000 | US6107482 Nitrogenous macrocyclic compounds |
| 08/22/2000 | US6107473 Kringle-related clone HTHBZ47 |
| 08/22/2000 | US6107464 iceA gene and related methods |
| 08/22/2000 | US6107458 Cyclic hexapeptides having antibiotic activity |
| 08/22/2000 | US6107349 Method and composition for treating psoriasis |
| 08/22/2000 | US6107347 Bimodal molecular weight hyaluronate formulations and methods for using same |
| 08/22/2000 | US6107346 Methods for treating hyperlipidemia |
| 08/22/2000 | US6107345 Antidepressant; psychological disorders |
| 08/22/2000 | US6107343 Ophthalmic and aural compositions containing diclofenac potassium |
| 08/22/2000 | US6107342 2-amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives and a process for the preparation thereof |
| 08/22/2000 | US6107338 Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists |
| 08/22/2000 | US6107335 Esculentin A and esculentin B, a process for their preparation, and their use in the manufacture of medicaments |
| 08/22/2000 | US6107334 Dietary control of arachidonic acid metabolism |
| 08/22/2000 | US6107333 Parenteral paclitaxel in a stable non-toxic formulation |
| 08/22/2000 | US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 08/22/2000 | US6107330 Inhibitor for narcotic analgesic dependence/resistance acquisition |
| 08/22/2000 | US6107329 Hypotensive agents; cardiovascular disorders |
| 08/22/2000 | US6107328 Use of 5HT1B receptor antagonist for the treatment of vascular disease |
| 08/22/2000 | US6107327 Therapeutic treatment for HIV infection |
| 08/22/2000 | US6107325 Green porphyrins as immunomodulators |
| 08/22/2000 | US6107324 5-HT2A receptor inverse agonists |
| 08/22/2000 | US6107323 Preventing or treating angiotensin diseases by administering an antagonist and compound which increases insulin sensitivity |
| 08/22/2000 | US6107320 Hypotensive agents |
| 08/22/2000 | US6107316 Method for treating protozoal infections |
| 08/22/2000 | US6107315 Nervous system disorders |
| 08/22/2000 | US6107312 Bactericide |
| 08/22/2000 | US6107311 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/22/2000 | US6107310 Heteroarylcarboxamide derivatives for treating CNS disorders |
| 08/22/2000 | US6107307 Psychological disorders |
| 08/22/2000 | US6107306 Heterocyclic compounds |
| 08/22/2000 | US6107305 Antiproferative agent, antiinflammatory agents |
| 08/22/2000 | US6107304 Anemia |
| 08/22/2000 | US6107303 Treatment of Epstein Barr infection |
| 08/22/2000 | US6107302 Storage stable valaciclovir in anhydrous crystalline form; viricide against herpes virus |
| 08/22/2000 | US6107301 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
| 08/22/2000 | US6107300 Arylamino fused pyrimidines |
| 08/22/2000 | US6107298 Methods for prevention and treatment of Tourette's syndrome and schizophrenia |
| 08/22/2000 | US6107297 2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists |
| 08/22/2000 | US6107296 Antiischemic agent |
| 08/22/2000 | US6107294 Nervous system and psychological disorders |
| 08/22/2000 | US6107291 Antiinflammatory agent |
| 08/22/2000 | US6107290 Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof |
| 08/22/2000 | US6107289 Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β |
| 08/22/2000 | US6107288 Antiviral nucleoside combination |
| 08/22/2000 | US6107284 Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments |
| 08/22/2000 | US6107283 Antitumor agents; diabetic therapy |
| 08/22/2000 | US6107282 Treatment of C. difficile toxin B associated conditions |
| 08/22/2000 | US6107281 Compounds and their combinations for the treatment of influenza infection |
| 08/22/2000 | US6107280 Administering bactericidal/permeability-increasing protein to delay or prevent clot formation in the blood or to enhance clot dissolution in blood |
| 08/22/2000 | US6107274 Enzyme inhibitors as hypoglycemic agents in treatment of type-ii diabetes |
| 08/22/2000 | US6107271 Neuroactive peptides |
| 08/22/2000 | US6107094 In vitro modification of target rna by contacting solution of target and ribonuclease preferential for double-stranded rna with oligonucleotide complementary to target and including nucleotides modified to improve affinity/specificity |
| 08/22/2000 | US6107086 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 08/22/2000 | US6107078 Ribozymes with optimized hybridizing arms, stems, and loops, tRNA embedded ribozymes and compositions thereof |
| 08/22/2000 | US6107073 Kinase capable of site-specific phosphorylation of IκBα |
| 08/22/2000 | US6107071 Polynucleotide or complementary sequence which codes for a specific staphylococcus aureus amino acid sequence; for diagnosis of bacterial infections; screening of bactericides, bacteriostats, and antibiotics |
| 08/22/2000 | US6107028 Prevention of viral replication or expression; insertion of a expression vector coding ribonucleic acid preferential proteolytic enzyme into cells infected with virus |
| 08/22/2000 | US6107027 Supression of viral gene expression in cells; transducing cells with a adenovirus vector which codes a protein which has preferential proteolytic activity for ribonucleic acids |
| 08/22/2000 | US6106874 Calcium fortified fruit beverages |
| 08/22/2000 | US6106871 Feeding ration of rumen protected choline to dairy cattle |
| 08/22/2000 | US6106864 Pharmaceutical formulations containing darifenacin |
| 08/22/2000 | US6106863 Sustained-release metal valproate tablets |
| 08/22/2000 | US6106862 Once daily analgesic tablet |
| 08/22/2000 | US6106861 Tablets that disintegrate in the mouth |
| 08/22/2000 | US6106859 Stabilization of lipid:DNA formulations during nebulization |
| 08/22/2000 | US6106858 Loading active materials of liposomes by dissolving |
| 08/22/2000 | US6106856 Drug delivery through skin |
| 08/22/2000 | US6106844 Administering to venom allergic patient |
| 08/22/2000 | US6106838 Pharmaceutical compositions containing herbal-based active ingredients; methods for preparing same and uses of same for medical and veterinary purposes |
| 08/22/2000 | US6106819 Administering anesthetic and antiinflammatory agent to eye |
| 08/22/2000 | US6106813 Polyester polyurethanes, process for preparing them, produced from the said polyester polyurethanes and their use in cosmetic compositions |